207 related articles for article (PubMed ID: 10449698)
1. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
Schulze-Neick I; Penny DJ; Rigby ML; Morgan C; Kelleher A; Collins P; Li J; Bush A; Shinebourne EA; Redington AN
Circulation; 1999 Aug; 100(7):749-55. PubMed ID: 10449698
[TBL] [Abstract][Full Text] [Related]
2. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease.
Matsui J; Yahagi N; Kumon K; Hayashi H; Watanabe Y; Haruna M; Tanigami H; Yagihara T; Takamoto S; Kamiya T
Artif Organs; 1997 Jan; 21(1):17-20. PubMed ID: 9012900
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass.
Wessel DL
Crit Care Med; 1993 Sep; 21(9 Suppl):S344-5. PubMed ID: 8395994
[No Abstract] [Full Text] [Related]
5. The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease.
Schulze-Neick I; Li J; Reader JA; Shekerdemian L; Redington AN; Penny DJ
J Thorac Cardiovasc Surg; 2002 Sep; 124(3):435-41. PubMed ID: 12202858
[TBL] [Abstract][Full Text] [Related]
6. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
Deb B; Bradford K; Pearl RG
Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of nitric oxide treatment for pulmonary hypertensive infants during cardiac anesthesia.
Kadosaki M; Kawamura T; Oyama K; Nara N; Wei J; Mori N
Anesthesiology; 2002 Apr; 96(4):835-40. PubMed ID: 11964589
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary hypertension in pediatric heart surgery].
Falcone N
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):462-4. PubMed ID: 11792301
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response.
Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP
Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
[TBL] [Abstract][Full Text] [Related]
12. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.
Stocker C; Penny DJ; Brizard CP; Cochrane AD; Soto R; Shekerdemian LS
Intensive Care Med; 2003 Nov; 29(11):1996-2003. PubMed ID: 14530859
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute pulmonary hypertension with inhaled nitric oxide.
Tönz M; von Segesser LK; Schilling J; Lüscher TF; Noll G; Leskosek B; Turina MI
Ann Thorac Surg; 1994 Oct; 58(4):1031-5. PubMed ID: 7944746
[TBL] [Abstract][Full Text] [Related]
15. No effect of L-arginine supplementation on pulmonary endothelial dysfunction after cardiopulmonary bypass.
Angdin M; Settergren G; Liska J; Astudillo R
Acta Anaesthesiol Scand; 2001 Apr; 45(4):441-8. PubMed ID: 11300382
[TBL] [Abstract][Full Text] [Related]
16. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease.
Miller OI; Celermajer DS; Deanfield JE; Macrae DJ
J Thorac Cardiovasc Surg; 1994 Sep; 108(3):487-94. PubMed ID: 8078341
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.
Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1104-10. PubMed ID: 9563726
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery.
Schulze-Neick I; Li J; Penny DJ; Redington AN
J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1033-9. PubMed ID: 11385367
[TBL] [Abstract][Full Text] [Related]
19. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.
Wessel DL; Adatia I; Giglia TM; Thompson JE; Kulik TJ
Circulation; 1993 Nov; 88(5 Pt 1):2128-38. PubMed ID: 8222107
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
Wang H; Gong M; Zhou B; Dai A
Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
